Identification of Let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancer
- 25 September 2020
- journal article
- research article
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 29 (1) , 101-110
Abstract
BACKGROUND: Among patients diagnosed with non-muscle invasive bladder cancer (NMIBC), 30% to 70% experience recurrences within 6 to 12 years of diagnosis. The need to screen for these events every 3 to 6 months and ultimately annually by cystoscopy makes bladder cancer one of the most expensive malignancies to manage. OBJECTIVE: The purpose of this study was to identify reproducible prognostic microRNAs in resected non-muscle invasive bladder tumor tissue that are predictive of the recurrent tumor phenotype as potential biomarkers and molecular therapeutic targets. METHODS: Two independent cohorts of NMIBC patients were analyzed using a biomarker discovery and validation approach, respectively. RESULTS: miRNA Let-7f-5p showed the strongest association with recurrence across both cohorts. Let-7f-5p levels in urine and plasma were both found to be significantly correlated with levels in tumor tissue. We assessed the therapeutic potential of targeting Lin28, a negative regulator of Let-7f-5p, with small-molecule inhibitor C1632. Lin28 inhibition significantly increased levels of Let-7f-5p expression and led to significant inhibition of viability and migration of HTB-2 cells. CONCLUSIONS: We have identified Let-7f-5p as a miRNA biomarker of recurrence in NMIBC tumors. We further demonstrate that targeting Lin28, a negative regulator of Let-7f-5p, represents a novel potential therapeutic opportunity in NMIBC.Keywords
This publication has 28 references indexed in Scilit:
- Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian CancerPLOS ONE, 2013
- Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell linesExperimental Cell Research, 2012
- Regulation of let-7 and its target oncogenes (Review)Oncology Letters, 2012
- Identifying Risk Factors in Patients With Non–Muscle-Invasive Bladder Cancer: Clinical ImplicationsEuropean Urology, 2011
- Identification of Methylated Genes Associated with Aggressive Bladder CancerPLOS ONE, 2010
- The role of let-7 in cell differentiation and cancerEndocrine-Related Cancer, 2010
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences of the United States of America, 2008
- The Causal Role of Cigarette Smoking in Bladder Cancer Initiation and Progression, and the Role of Urologists in Smoking CessationJournal of Urology, 2008
- Sulforhodamine B colorimetric assay for cytotoxicity screeningNature Protocols, 2006
- Local recurrence after radical cystectomy for invasive bladder cancer: An analysis of predictive factorsUrology, 2004